Arcus Biosciences, Inc. (RCUS)
Total Valuation
RCUS has a market cap or net worth of $1.29 billion. The enterprise value is $279.65 million.
Market Cap | 1.29B |
Enterprise Value | 279.65M |
Important Dates
The next earnings date is Monday, May 8, 2023, after market close.
Estimated Earnings Date | May 8, 2023 |
Ex-Dividend Date | n/a |
Share Statistics
RCUS has 73.01 million shares outstanding. The number of shares has decreased by -2.70% in one year.
Shares Outstanding | 73.01M |
Shares Change (YoY) | -2.70% |
Shares Change (QoQ) | +0.70% |
Owned by Insiders (%) | 28.71% |
Owned by Institutions (%) | 75.90% |
Float | 49.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 11.51 |
Forward PS | 7.01 |
PB Ratio | 1.96 |
P/FCF Ratio | 2.98 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.50 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 0.65 |
Financial Position
The company has a current ratio of 5.53
Current Ratio | 5.53 |
Quick Ratio | 5.43 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -36.80% and return on invested capital (ROIC) is -25.50%.
Return on Equity (ROE) | -36.80% |
Return on Assets (ROA) | -18.50% |
Return on Capital (ROIC) | -25.50% |
Revenue Per Employee | $306,011 |
Profits Per Employee | -$729,508 |
Employee Count | 366 |
Asset Turnover | 0.08 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $1.00 million in taxes.
Income Tax | 1.00M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.96% in the last 52 weeks. The beta is 0.88, so RCUS's price volatility has been lower than the market average.
Beta (1Y) | 0.88 |
52-Week Price Change | -51.96% |
50-Day Moving Average | 19.27 |
200-Day Moving Average | 24.44 |
Average Volume (30 Days) | 1,127,243 |
Short Selling Information
The latest short interest is 6.67 million, so 9.13% of the outstanding shares have been sold short.
Short Interest | 6.67M |
Short Previous Month | 6.51M |
Short % of Shares Out | 9.13% |
Short % of Float | 13.53% |
Short Ratio (days to cover) | 6.91 |
Income Statement
In the last 12 months, RCUS had revenue of $112.00 million and -$267.00 million in losses. Loss per share was -$3.71.
Revenue | 112.00M |
Gross Profit | 112.00M |
Operating Income | -280.00M |
Pretax Income | -266.00M |
Net Income | -267.00M |
EBITDA | -252.00M |
EBIT | -266.00M |
Loss Per Share | -$3.71 |
Balance Sheet
Cash & Cash Equivalents | 1.01B |
Total Debt | n/a |
Net Cash | 1.01B |
Net Cash Per Share | $13.82 |
Equity / Book Value | 657.00M |
Book Value Per Share | 9.00 |
Working Capital | 874.00M |
Cash Flow
In the last 12 months, operating cash flow was $438.00 million and capital expenditures -$6.00 million, giving a free cash flow of $432.00 million.
Operating Cash Flow | 438.00M |
Capital Expenditures | -6.00M |
Free Cash Flow | 432.00M |
FCF Per Share | $6.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -250.00% and -238.39%.
Gross Margin | 100.00% |
Operating Margin | -250.00% |
Pretax Margin | -237.50% |
Profit Margin | -238.39% |
EBITDA Margin | -225.00% |
EBIT Margin | -237.50% |
FCF Margin | 385.71% |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -20.72% |
FCF Yield | 33.52% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.70% |
Shareholder Yield | 2.70% |
Analyst Forecast
The average price target for RCUS is $44.29, which is 150.94% higher than the current price. The consensus rating is "Buy".
Price Target | $44.29 |
Price Target Difference | 150.94% |
Analyst Consensus | Buy |
Analyst Count | 19 |
Revenue Growth Forecast (5Y) | 41.66% |
EPS Growth Forecast (5Y) | -3.21% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |